COMPARATIVE EFFECTIVENESS AND SAFETY OF ANTITHROMBOTIC THERAPY IN OLDER PATIENTS WITH ATRIAL FIBRILLATION AND NON-ST ELEVATION MYOCARDIAL INFARCTION (NSTEMI) TREATED WITH CORONARY STENTING
Emil Loldrup Fosbøl(University of Copenhagen), Eric D. Peterson(The University of Texas Southwestern Medical Center), Roger M. Mills(Janssen (Belgium)), Matthew T. Roe(Clinical Research Institute), Renato D. Lópes(Duke University), Tracy Wang(Medical College of Wisconsin), Winslow Klaskala(Johnson & Johnson (United States)), Shuang Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jonathan P. Piccini(Clinical Research Institute)
Cited by 0
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
|Circulation|2011|1.8k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k